Guy Lacombe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Guy Lacombe has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Tamas Fulop
Department of Medicine, Geriatrics Service, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 4N4, Canada
3 shared publications - Abdelouahed Khalil
Department of Medicine, Geriatrics Service, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 4N4, Canada
1 shared publication - Alan A. Cohen
Department of Environmental Health Sciences, Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, NY, USA
1 shared publication - Anis Larbi
Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke
1 shared publication Caroline Giguere
Societe Alzheimer de l'Estrie, Sherbrooke, QC, Canada
1 shared publicationChantale Leblanc
Department of Internal Medicine and Centre de Recherche en Gérontologie et Gériatrie, Université de Sherbrooke, Faculté de Médecine, Hôpital d'Youville, Sherbrooke, Quebec, Canada
1 shared publication
Latest Publications
- Open Access
- 25 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S4) , e099511
Estern township Alzheimer Society, 40 years of development and collaboration for the patient and cargivers
The Alzheimer Society of the Eastern Townships began 40 years ago with 6 volunteers bringing together professionals and caregivers to provide information to the families of people with Alzheimer's disease in the Sherbrooke region. As a non‐profit company, it was financed by donations from the public to pay for equipment and installation. It has gradually extended its services to the entire region covering more than 1100 square km and a population of 300,000 inhabitants. It now offers training to professionals and caregivers. Lectures by health professionals, lawyers and psychologists, monthly and open to the general public, cover the psychological, biological, social and legal components of Alzheimer's disease and related diseases. Day centres offer creative and enhancement activities in addition to music and pet therapy, no competent animators. In‐home respite services by trained staff help with home care. Supervised peer meetings reach both people with dementia and caregivers. A monthly newsletter is published and a dynamic but easy‐to‐access website is updated weekly. She collaborates with the Quebec Federation of Alzheimer and Alzheimer Societies Canada. The annual budget of a few thousand dollars now exceeds $1.5 million, partly supported by government subsidies for services not available in the public system. A house for temporary stays will soon be in operation
- 25 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S4) , e099511
Open AccessEstern township Alzheimer Society, 40 years of development and collaboration for the patient and cargivers
The Alzheimer Society of the Eastern Townships began 40 years ago with 6 volunteers bringing together professionals and caregivers to provide information to the families of people with Alzheimer's disease in the Sherbrooke region. As a non‐profit company, it was financed by donations from the public to pay for equipment and installation. It has gradually extended its services to the entire region covering more than 1100 square km and a population of 300,000 inhabitants. It now offers training to professionals and caregivers. Lectures by health professionals, lawyers and psychologists, monthly and open to the general public, cover the psychological, biological, social and legal components of Alzheimer's disease and related diseases. Day centres offer creative and enhancement activities in addition to music and pet therapy, no competent animators. In‐home respite services by trained staff help with home care. Supervised peer meetings reach both people with dementia and caregivers. A monthly newsletter is published and a dynamic but easy‐to‐access website is updated weekly. She collaborates with the Quebec Federation of Alzheimer and Alzheimer Societies Canada. The annual budget of a few thousand dollars now exceeds $1.5 million, partly supported by government subsidies for services not available in the public system. A house for temporary stays will soon be in operation
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S4)
Quebec Eastern Township Regional Dementia Care Update after COVID. Reorganisation for the Quebec Ministerial Alzheimer program
Background: In the province of Quebec, Canada, primary care management of Alzheimer’s disease is provided by the Family Medicine Group with the support of the Ministerial Initiative on Alzheimer’s Disease and the collaboration of specialized memory clinics. The COVID years have severely strained health resources in all areas, including cognitive intervention resources. We describe the reorganization of regional support in the Eastern Townships.Method: The results of a survey on the situation of care are shared with each of the family medicine groups involved in the Eastern Townships Alzheimer Plan, comparing the processes and results of each team to the provincial average. The difficulties and improvements proposed by each of the groups are noted and discussed with a view to continuous improvement.Result: A regional tour was necessary to re‐establish contact between the regional support resources (nurse and doctors of the memory clinic) and the Family Medicine Group. Nursing, medical, and pharmaceutical staff and social workers were met at each FMG. Interdisciplinary care models, local resources, leaderchip and development opportunities were discussed. Training needs have been identified. Demands to involve social workers and pharmacists are growing. The evolution of the clientele is striking, with a significant increase in the number of evaluations for patients with mild neurocognitive disorders.Conclusion: The presence of at least one experienced person at each FMG made it possible to reorganize the clinics after the staff changes related to the COVID period. The tour allows us to recreate the links that are essential to the development of expertise and to provide specialized support to the family medicine groups involved in the Alzheimer’s plan.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S4)
Open AccessQuebec Eastern Township Regional Dementia Care Update after COVID. Reorganisation for the Quebec Ministerial Alzheimer program
Background: In the province of Quebec, Canada, primary care management of Alzheimer’s disease is provided by the Family Medicine Group with the support of the Ministerial Initiative on Alzheimer’s Disease and the collaboration of specialized memory clinics. The COVID years have severely strained health resources in all areas, including cognitive intervention resources. We describe the reorganization of regional support in the Eastern Townships.Method: The results of a survey on the situation of care are shared with each of the family medicine groups involved in the Eastern Townships Alzheimer Plan, comparing the processes and results of each team to the provincial average. The difficulties and improvements proposed by each of the groups are noted and discussed with a view to continuous improvement.Result: A regional tour was necessary to re‐establish contact between the regional support resources (nurse and doctors of the memory clinic) and the Family Medicine Group. Nursing, medical, and pharmaceutical staff and social workers were met at each FMG. Interdisciplinary care models, local resources, leaderchip and development opportunities were discussed. Training needs have been identified. Demands to involve social workers and pharmacists are growing. The evolution of the clientele is striking, with a significant increase in the number of evaluations for patients with mild neurocognitive disorders.Conclusion: The presence of at least one experienced person at each FMG made it possible to reorganize the clinics after the staff changes related to the COVID period. The tour allows us to recreate the links that are essential to the development of expertise and to provide specialized support to the family medicine groups involved in the Alzheimer’s plan.
- Open Access
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Organismal ageing is associated with many physiological changes, including differences in the immune system of most animals. These differences are often considered to be a key cause of age-associated diseases as well as decreased vaccine responses in humans. The most often cited vaccine failure is seasonal influenza, but, while it is usually the case that the efficiency of this vaccine is lower in older than younger adults, this is not always true, and the reasons for the differential responses are manifold. Undoubtedly, changes in the innate and adaptive immune response with ageing are associated with failure to respond to the influenza vaccine, but the cause is unclear. Moreover, recent advances in vaccine formulations and adjuvants, as well as in our understanding of immune changes with ageing, have contributed to the development of vaccines, such as those against herpes zoster and SARS-CoV-2, that can protect against serious disease in older adults just as well as in younger people. In the present article, we discuss the reasons why it is a myth that vaccines inevitably protect less well in older individuals, and that vaccines represent one of the most powerful means to protect the health and ensure the quality of life of older adults.
Open AccessImmunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Organismal ageing is associated with many physiological changes, including differences in the immune system of most animals. These differences are often considered to be a key cause of age-associated diseases as well as decreased vaccine responses in humans. The most often cited vaccine failure is seasonal influenza, but, while it is usually the case that the efficiency of this vaccine is lower in older than younger adults, this is not always true, and the reasons for the differential responses are manifold. Undoubtedly, changes in the innate and adaptive immune response with ageing are associated with failure to respond to the influenza vaccine, but the cause is unclear. Moreover, recent advances in vaccine formulations and adjuvants, as well as in our understanding of immune changes with ageing, have contributed to the development of vaccines, such as those against herpes zoster and SARS-CoV-2, that can protect against serious disease in older adults just as well as in younger people. In the present article, we discuss the reasons why it is a myth that vaccines inevitably protect less well in older individuals, and that vaccines represent one of the most powerful means to protect the health and ensure the quality of life of older adults.
- 1 November 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 382, 79-83
Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment
- 1 November 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 382, 79-83
Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment
- 13 November 1995
- Published by Wiley in FEBS Letters
- Vol. 375 (1-2) , 69-74
Cellular distribution of protein kinase C isozymes in CD3‐mediated stimulation of human T lymphocytes with aging
Protein kinase C (PKC) is involved in a variety of cellular responses, such as the expression and secretion of IL‐2, the regulation of cytotoxic killing and cell proliferation. It is known that these immune functions are altered with aging. Here, we show that anti‐CD3‐triggered T cell proliferation is significantly decreased with aging and that H7, an inhibitor of PKC, impairs the anti‐CD3‐induced T cell proliferation in a differential manner, lymphocytes of healthy young subjects being more sensitive to the PKC inhibitor than those of elderly subjects. We examined (Western blot) the presence and the cellular distribution of PKC isozymes in T lymphocytes of healthy young and elderly subjects in the resting state and after anti‐CD3 mAb stimulation using antibodies directed against PKC α, β, δ, ϵ and ζ isoforms in the cytosol and the plasma membrane fractions. These five PKC isotypes were present in human T cells of young and elderly subjects. However, their distribution between the cytosolic and membrane fractions varied according to the isozymes and the age of the subjects. In resting lymphocytes of young subjects, all the PKC isozymes were found in the cytosolic fraction, except PKC‐ζ. In resting lymphocytes of elderly subjects PKC‐δ and ‐ϵ were almost equally distributed between the cytosolic and the membrane fractions, whereas PKC‐α and ‐ζ were mainly found in the membrane fraction and PKC‐β was almost exclusively located in the cytosolic fraction. The translocation of PKC‐α, ‐β, ‐δ and ‐ϵ could be observed under anti‐CD3 mAb stimulation in lymphocytes of young subjects, while in the case of elderly subjects only the PKC β isoform was translocated. Our results suggest that the decreased availability of cytosolic PKC may contribute to the diminished PKC‐dependent responses to CD3‐triggered stimulation of human T lymphocytes with aging.
- 13 November 1995
- Published by Wiley in FEBS Letters
- Vol. 375 (1-2) , 69-74
Cellular distribution of protein kinase C isozymes in CD3‐mediated stimulation of human T lymphocytes with aging
Protein kinase C (PKC) is involved in a variety of cellular responses, such as the expression and secretion of IL‐2, the regulation of cytotoxic killing and cell proliferation. It is known that these immune functions are altered with aging. Here, we show that anti‐CD3‐triggered T cell proliferation is significantly decreased with aging and that H7, an inhibitor of PKC, impairs the anti‐CD3‐induced T cell proliferation in a differential manner, lymphocytes of healthy young subjects being more sensitive to the PKC inhibitor than those of elderly subjects. We examined (Western blot) the presence and the cellular distribution of PKC isozymes in T lymphocytes of healthy young and elderly subjects in the resting state and after anti‐CD3 mAb stimulation using antibodies directed against PKC α, β, δ, ϵ and ζ isoforms in the cytosol and the plasma membrane fractions. These five PKC isotypes were present in human T cells of young and elderly subjects. However, their distribution between the cytosolic and membrane fractions varied according to the isozymes and the age of the subjects. In resting lymphocytes of young subjects, all the PKC isozymes were found in the cytosolic fraction, except PKC‐ζ. In resting lymphocytes of elderly subjects PKC‐δ and ‐ϵ were almost equally distributed between the cytosolic and the membrane fractions, whereas PKC‐α and ‐ζ were mainly found in the membrane fraction and PKC‐β was almost exclusively located in the cytosolic fraction. The translocation of PKC‐α, ‐β, ‐δ and ‐ϵ could be observed under anti‐CD3 mAb stimulation in lymphocytes of young subjects, while in the case of elderly subjects only the PKC β isoform was translocated. Our results suggest that the decreased availability of cytosolic PKC may contribute to the diminished PKC‐dependent responses to CD3‐triggered stimulation of human T lymphocytes with aging.